Skip to main content
. 2018 May 11;8(5):42. doi: 10.1038/s41408-018-0075-6

Fig. 4.

Fig. 4

a Serum Semaphorin 4D (Sema4D) levels of multiple myeloma patients compared to controls (p < 0.001). b Serum Plexin-B1 levels of multiple myeloma patients compared to controls (p = 0.01)